Helping eligible patients with financial hardship
obtain medication

Aptalis Pharma US, Inc. is dedicated to improving the quality of care and health of patients suffering from cystic fibrosis and gastrointestinal disorders by providing effective therapies for patients and their caregivers. They are also committed to helping ease the financial burden of healthcare for patients in need.

The Aptalis Patient Assistance Program (PAP) was designed for patients experiencing financial hardship who earn too much to qualify for government-funded programs, but don’t have third-party coverage. The Aptalis PAP allows these patients greater access to the Aptalis medication prescribed by their doctor.

Covered medications include: